Nob Hill Therapeutics, Inc. is developing the first dry powder nebulizer (DPN) for the treatment of severe respiratory diseases, including non-cystic fibrosis bronchiectasis and lung infections.
Nebulizers deliver more predictable, superior therapy compared to inhalers and are the preferred method of treatment for elderly and pediatric patients. However, their usage has been limited because today’s nebulizers are bulky, cumbersome to operate and require a long therapy time.
As a result, nebulizers are typically reserved for hospitals, emergency rooms, home care, and nursing homes where predictable, consistent treatment is imperative.
Since nebulizers remain the most reliable way to deliver therapy into deep lungs , there is a growing demand for a more portable, easy-to-use nebulizer.
Location: United States, New Mexico, Albuquerque
Member count: 11-50
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | VIC Techno... | victech.co... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 23.08.2022 | Nob Hill T... | “I’m thrilled to join Nob Hill... | - | - | prweb.com/... |
| 22.11.2021 | Nob Hill T... | Dr. Pritchard commented “I am ... | - | - | prweb.com/... |
| 20.04.2021 | Nob Hill T... | Dr. Paul J. Atkins "I am ... | - | - | prweb.com/... |